Mirum Pharmaceuticals (MIRM) Change in Cash (2019 - 2026)

Mirum Pharmaceuticals' Change in Cash history runs 8 years deep, the most recent figure standing at $28.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 366.59% year-over-year to $28.5 million; the TTM figure through Mar 2026 stood at $114.4 million (up 226.27% YoY), while the FY2025 annual figure was $75.2 million, up 218.67% from the prior year.
• Change in Cash for Q1 2026 stood at $28.5 million, up from $15.7 million in the prior quarter.
• The five-year high for Change in Cash was $147.8 million in Q2 2023, with the low at -$69.3 million in Q2 2024.
• The 5-year median for Change in Cash is $9.0 million (2022), against an average of $11.5 million.
• The sharpest annual moves came in 2024 and 2025: Change in Cash tumbled 273.23% in 2024, then soared 3461.37% in 2025.
• Mirum Pharmaceuticals' Change in Cash stood at -$7.8 million in 2022, then slumped by 115.74% to -$16.7 million in 2023, then jumped by 97.22% to -$466000.0 in 2024, then jumped by 3461.37% to $15.7 million in 2025, then surged by 81.79% to $28.5 million in 2026.
• Business Quant data shows MIRM's Change in Cash at $28.5 million in Q1 2026, $15.7 million in Q4 2025, and $53.9 million in Q3 2025.